Pulmicort HFA
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pulmicort HFA, covering 2012-08-27 to 2012-08-27. Get the full timeline:
Most recent: Clinical Trial Update: An Efficacy Study Comparing SYMBICORT® Pressurised Metered Dose Inhaler (pMDI) With Budesonide Hydrofluoroalkanes (HFA) pMDI, in Hispanic Subjects With ICS Dependent Asthma [Phase 3]